Oruka Therapeutics, Stock Market Value
| ORKA Stock | 20.75 0.25 1.22% |
| Symbol | Oruka |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Oruka Therapeutics,. If investors know Oruka will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Oruka Therapeutics, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Oruka Therapeutics, is measured differently than its book value, which is the value of Oruka that is recorded on the company's balance sheet. Investors also form their own opinion of Oruka Therapeutics,'s value that differs from its market value or its book value, called intrinsic value, which is Oruka Therapeutics,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Oruka Therapeutics,'s market value can be influenced by many factors that don't directly affect Oruka Therapeutics,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Oruka Therapeutics,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if Oruka Therapeutics, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Oruka Therapeutics,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Oruka Therapeutics, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Oruka Therapeutics,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Oruka Therapeutics,.
| 10/26/2024 |
| 11/25/2024 |
If you would invest 0.00 in Oruka Therapeutics, on October 26, 2024 and sell it all today you would earn a total of 0.00 from holding Oruka Therapeutics, or generate 0.0% return on investment in Oruka Therapeutics, over 30 days. Oruka Therapeutics, is related to or competes with Eliem Therapeutics, HCW Biologics, Scpharmaceuticals, Milestone Pharmaceuticals, Seres Therapeutics, and Lumos Pharma. Oruka Therapeutics, is entity of United States More
Oruka Therapeutics, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Oruka Therapeutics,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Oruka Therapeutics, upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.03) | |||
| Maximum Drawdown | 46.36 | |||
| Value At Risk | (11.46) | |||
| Potential Upside | 8.25 |
Oruka Therapeutics, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Oruka Therapeutics,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Oruka Therapeutics,'s standard deviation. In reality, there are many statistical measures that can use Oruka Therapeutics, historical prices to predict the future Oruka Therapeutics,'s volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (1.16) | |||
| Treynor Ratio | (0.04) |
Oruka Therapeutics, Backtested Returns
Oruka Therapeutics, maintains Sharpe Ratio (i.e., Efficiency) of -0.0128, which implies the firm had a -0.0128% return per unit of risk over the last 3 months. Oruka Therapeutics, exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Oruka Therapeutics,'s Variance of 44.98, insignificant risk adjusted performance, and Coefficient Of Variation of (7,462) to confirm the risk estimate we provide. The company holds a Beta of 2.29, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Oruka Therapeutics, will likely underperform. At this point, Oruka Therapeutics, has a negative expected return of -0.0855%. Please make sure to check Oruka Therapeutics,'s rate of daily change, and the relationship between the kurtosis and market facilitation index , to decide if Oruka Therapeutics, performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.93 |
Excellent predictability
Oruka Therapeutics, has excellent predictability. Overlapping area represents the amount of predictability between Oruka Therapeutics, time series from 26th of October 2024 to 10th of November 2024 and 10th of November 2024 to 25th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Oruka Therapeutics, price movement. The serial correlation of 0.93 indicates that approximately 93.0% of current Oruka Therapeutics, price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.93 | |
| Spearman Rank Test | 0.87 | |
| Residual Average | 0.0 | |
| Price Variance | 4.79 |
Oruka Therapeutics, lagged returns against current returns
Autocorrelation, which is Oruka Therapeutics, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Oruka Therapeutics,'s stock expected returns. We can calculate the autocorrelation of Oruka Therapeutics, returns to help us make a trade decision. For example, suppose you find that Oruka Therapeutics, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Oruka Therapeutics, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Oruka Therapeutics, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Oruka Therapeutics, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Oruka Therapeutics, stock over time.
Current vs Lagged Prices |
| Timeline |
Oruka Therapeutics, Lagged Returns
When evaluating Oruka Therapeutics,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Oruka Therapeutics, stock have on its future price. Oruka Therapeutics, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Oruka Therapeutics, autocorrelation shows the relationship between Oruka Therapeutics, stock current value and its past values and can show if there is a momentum factor associated with investing in Oruka Therapeutics,.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Oruka Therapeutics, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Oruka Therapeutics,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Oruka Therapeutics, Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Oruka Therapeutics, Stock:Check out Oruka Therapeutics, Correlation, Oruka Therapeutics, Volatility and Oruka Therapeutics, Alpha and Beta module to complement your research on Oruka Therapeutics,. For information on how to trade Oruka Stock refer to our How to Trade Oruka Stock guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Oruka Therapeutics, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.